UCB SA (UCB.BR) — Quality & forensics
As of 2026-09-22 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.
The Closelook module scores
- Valuation 58
- Quality 70
- Growth 74
- Balance sheet 63
- Cash quality 55
- Capital allocation 61
- Momentum 16
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the UCB.BR chart & overview
FAQ · from the current data · as of 2026-09-22
Quick answers
What is UCB SA's Closelook quality reading?
The composite reads 60/100 across 7 modules, as of 2026-09-22: valuation 58, quality 70, growth 74, balance sheet 63, cash quality 55, capital allocation 61, momentum 16. Closelook scores are research diary readings, not ratings or investment advice.
What is UCB SA's Altman Z-Score?
4.71, which sits in the safe zone (above 2.99) as of 2026-09-22. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is UCB SA's Piotroski F-Score?
8 of 9, as of 2026-09-22. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does UCB SA's Beneish M-Score indicate?
-2.28 — below the −1.78 manipulation-risk threshold, as of 2026-09-22. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- DNA Ginkgo Bioworks Holdingsindustry
- RXRX Recursion Pharmaceuticals Incindustry
- IBRX Immunitybio Incindustry
- HALO Halozyme Therapeutics Incindustry
- SMMT Summit Therapeutics PLCindustry
- SRPT Sarepta Therapeutics Incindustry
- GMAB Genmab ASindustry
- CRSP Crispr Therapeutics AGindustry
- TGTX TG Therapeutics Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- EXEL Exelixis Incindustry